Neurology Clinical Trials

Hightower's neurology clinical trials focus on developing new treatments for a range of neurological conditions.

Neurology Clinical Trials in Oklahoma City, OK

Neurology clinical trials provide patients with access to potential treatments and the opportunity to contribute to vital research that can lead to better outcomes for future generations.Join Hightower Clinical in advancing neurological health and enhancing the lives of those affected by these challenging disorders.

Focal Seizures

Hightower Clinical is conducting clinical trials for adults with focal seizures. These seizures begin in one part of the brain and may cause symptoms ranging from sensory disturbances to full-body convulsions. These trials aim to evaluate a potential treatment for individuals who still experience seizures despite taking 1–3 anti-seizure medications. Participants receive expert, study-related care at no cost. The research hopes to improve seizure control and overall quality of life for those affected.

Enroll Now

Age

18 Years to 75 Years

Gender

Both 

Condition

Focal Seizure 

Current Status

Recruiting

Location

Oklahoma

Study Information

Peripheral Vascular Disease

Study NameProtocol NumberSponsor
Focal Seizures

POWER 1 PRAX-628-321

Praxis Precision Medicines

Librexia Stroke

Explore the Librexia Stroke clinical trials in Oklahoma City, OK, where you can help advance research for effective stroke management. Stroke remains a leading cause of mortality and disability, highlighting the urgent need for improved treatments. Hightower Clinical is conducting a Phase 3 study to evaluate an investigational drug’s safety and efficacy for stroke survivors. Participation is free of cost and voluntary, with comprehensive care provided by expert physicians. Don’t miss your chance to make a difference—fill out the form to learn more about your eligibility today!

Enroll Now

Age

40 years and older

Gender

All

Condition

Librexia Stroke

Current Status

Recruiting

Location

Oklahoma

Study Information

Stroke

Study NameProtocol NumberSponsor
Stroke

CR109231

Janssen